Description

Curative health is a disease management company in the chronic wound care industry.
Company is profitable, has a nice cash balance on the books, and is actively buying
back shares of their own stock. Given the current market environment, it is my opinion
that shares are less susceptable to a downturn than most stocks and that for patient holders
some capital appreciation is quite possible. Target price of 8 to 10 a share gives a return of
60 to 70%, which is pretty respectable. That return could be much higher if the company
executes and profits return to prior histroic levels. Company has 5.86 a share in cash, no debt,
and a price to sales ratio of a low .67. The company also just sold part of the business which was not
performing up to standards which should allow them to concentrate on the rest of the business and get
profits band growth back on track.

Catalyst

The current low valuation has this gem valued at what they have in cash.
That, considering the company is making money and the prospects seem to be
improving and the company is buying back stock, make this an attreactive
investment for longer term shareholders. I have a target of 10 a share by december.